Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
- PMID: 33531981
- PMCID: PMC7847656
- DOI: 10.7150/jca.52349
Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
Abstract
Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treated with GKRS were retrospectively reviewed in a single center. There were 271 male (36.1%) and 480 female (63.9%) patients with a median age of 38.5 (range, 7.2-84.0) years. The number of nonfunctioning pituitary adenomas (NFPAs) and functioning pituitary adenomas were 369 (49.1%) and 382 (50.9%) respectively. The median follow-up time was 61.1 (range, 12.1-304.4) months. Results: In this study, 88 patients (11.7%) were diagnosed with pituitary hemorrhage before GKRS, 55 patients (7.3%) developed new or worsened pituitary hemorrhage after GKRS (excluding 3 patients with new or worsened pituitary hemorrhage due to tumor regrowth). The median time to new or worsened pituitary hemorrhage after GKRS was 18.9 (range 3.1-70.7) months. Overall, 128 patients (17.0%) were diagnosed with pituitary hemorrhage in the entire series. After adjustment with logistic regression, nonfunctioning pituitary adenomas (NFPAs) (odds ratio [OR]=2.121, 95% confidence interval [CI]=1.195-3.763, p=0.010) and suprasellar extension (OR=2.470, 95% CI=1.361-4.482, p=0.003) were associated with pituitary hemorrhage before GKRS. NFPA (OR=3.271, 95% CI=1.278-8.373, p=0.013) was associated with new or worsened pituitary hemorrhage after GKRS. Five patients received surgical resection for new or worsened pituitary hemorrhage were considered as GKRS treatment failure. Two patients with new hypopituitarism were considered to be owed to new or worsened pituitary hemorrhage after GKRS. Conclusions: New or worsened pituitary hemorrhage after GKRS was not an uncommon phenomenon. NFPA was an independent risk factor of new or worsened pituitary hemorrhage after GKRS. New or worsened pituitary hemorrhage after GKRS could lead to GKRS treatment failure. GKRS might be a precipitating factor of pituitary hemorrhage.
Keywords: gamma knife; pituitary adenoma; pituitary apoplexy; pituitary hemorrhage; radiosurgery.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures

Similar articles
-
Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: long-term results from a single-center experience.BMC Cancer. 2024 Aug 6;24(1):963. doi: 10.1186/s12885-024-12735-3. BMC Cancer. 2024. PMID: 39107688 Free PMC article.
-
Characteristic of Tumor Regrowth After Gamma Knife Radiosurgery and Outcomes of Repeat Gamma Knife Radiosurgery in Nonfunctioning Pituitary Adenomas.Front Oncol. 2021 Mar 5;11:627428. doi: 10.3389/fonc.2021.627428. eCollection 2021. Front Oncol. 2021. PMID: 33763363 Free PMC article.
-
Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas: results from a 26-year experience.Endocrine. 2020 May;68(2):399-410. doi: 10.1007/s12020-020-02260-1. Epub 2020 Mar 11. Endocrine. 2020. PMID: 32162186
-
The Efficacy of Gamma Knife Radiosurgery for Cavernous Malformations: A Meta-Analysis and Review.World Neurosurg. 2019 Mar;123:371-377. doi: 10.1016/j.wneu.2018.12.046. Epub 2018 Dec 22. World Neurosurg. 2019. PMID: 30583131 Review.
-
Retreatment of vestibular schwannoma with Gamma Knife radiosurgery: clinical outcome, tumor control, and review of literature.J Neurosurg. 2018 Jul;129(1):137-145. doi: 10.3171/2017.3.JNS162033. Epub 2017 Oct 6. J Neurosurg. 2018. PMID: 28984523 Review.
Cited by
-
Fractionated robotic radiosurgery for unfavorable nonfunctioning pituitary macroadenoma: 5-year outcomes from a single institution protocol.Front Oncol. 2025 Feb 4;15:1519445. doi: 10.3389/fonc.2025.1519445. eCollection 2025. Front Oncol. 2025. PMID: 39968072 Free PMC article.
-
Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas.Neurosurgery. 2025 Apr 1;96(4):892-900. doi: 10.1227/neu.0000000000003174. Epub 2024 Sep 12. Neurosurgery. 2025. PMID: 39264192
-
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5. Pituitary. 2024. PMID: 39102126 Free PMC article. Review.
-
Pituitary Apoplexy: An Updated Review.J Clin Med. 2024 Apr 24;13(9):2508. doi: 10.3390/jcm13092508. J Clin Med. 2024. PMID: 38731037 Free PMC article. Review.
References
-
- Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML. et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004;101:613–9. - PubMed
-
- Bills DC, Meyer FB, Laws ER Jr, Davis DH, Ebersold MJ, Scheithauer BW. et al. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993;33:602–8. discussion 8-9. - PubMed
-
- Raappana A, Koivukangas J, Ebeling T, Pirila T. Incidence of pituitary adenomas in Northern Finland in 1992-2007. The Journal of clinical endocrinology and metabolism. 2010;95:4268–75. - PubMed
-
- Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK) Clinical endocrinology. 2010;72:377–82. - PubMed
-
- Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. The Journal of clinical endocrinology and metabolism. 1995;80:2190–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources